3 patents
Utility
Methods of Treating Metastatic Cancers Using Axl Decoy Receptors
11 Jan 24
Compositions and methods are provided for treating a human metastatic cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL protein activity, for example by inhibition of the binding interaction between AXL and its ligand GAS6.
Gail McIntyre, David Prohaska, Ray Tabibiazar
Filed: 1 Aug 23
Utility
Diagnostic Methods for Cancer Using Axl Decoy Receptors
7 Sep 23
The present invention provides therapeutic and diagnostic methods and compositions for treating a human metastatic cancer.
Gail McIntyre, Ray Tabibiazar, Elisabeth Gardiner
Filed: 18 Jul 21
Utility
METHODS OF TREATING CLEAR CELL RENAL CELL CARCINOMA (ccRCC) USING AXL DECOY RECEPTORS
16 Mar 23
Compositions and methods are provided for treating advanced clear cell renal cell carcinoma (RCC) in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits AXL protein activity, for example by inhibition of the binding interaction between AXL and its ligand GAS6, in combination with a therapeutic dose of cabozantinib.
Gail MCINTYRE, Laura BONIFACIO
Filed: 5 Jan 21
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first